Articles from DSI Assignments
Strategic Acquisition Opportunity: VintaBio's Viral Vector Manufacturing Facility, Specialized Equipment and Proprietary Technology Assets Available for Bids
The Assignee of VintaBio, Inc., a leader in advanced viral vector and vaccine manufacturing, is inviting bids for the company's assets, including a purpose-built cGMP facility, specialized bioprocessing equipment, and related intellectual property and proprietary manufacturing know-how. Following VintaBio's Assignment for the Benefit of Creditors on October 27, 2026, the Assignee is seeking competitive offers for these specialized biotechnology manufacturing assets.
By DSI Assignments · Via Business Wire · November 3, 2026